Ab-Chminaca Legal Deutschland

and is illegal in some countries around the world, including Germany since 2015. It was first synthesized by the pharmaceutical company Pfirzer as a potential drug due to its strong binding to the cannabinoid receptor CB1, but then found its way into the research chemicals market as a semi-legal synthetic drug. AB-CHMINACA is an illegal substance in the Russian Federation. AB-CHMINACA has been illegal in Switzerland since December 2015. [13] It has also been illegal in the United States since 2015, as well as in China and Switzerland. Synthetic cannabinoid receptor agonists (commonly referred to as “synthetic cannabinoids”) are a group of substances that mimic the effects of (–)-trans-Δ9-tetrahydrocannabinol (THC). THC is the substance primarily responsible for the essential psychoactive effects of cannabis. Like THC, synthetic cannabinoids bind to cannabinoid receptors in the body. This is why these substances are used to produce many “high legal” products that are sold as legal substitutes for cannabis.

This is the largest group of new psychoactive substances monitored by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Since the emergence of the phenomenon of synthetic cannabinoids on the market, these substances are mainly contained in products marketed under the name of “herbal smoking mixtures”. Recently, however, it has been reported in several countries that these substances have also been detected in products that appear to be cannabis resin, either in the form of “high legal” products such as “Afghan incense”, or on the illegal market, where they are dispensed in the form of cannabis resin. This development is probably a reaction to the popularity of cannabis resin in many countries. Synthetic cannabinoids have also been found in mixtures containing other new psychoactive substances, such as stimulants, hallucinogens, and sedatives/hypnotics. This can be both intentional and unintentional. In a few cases, synthetic cannabinoids have also been detected in tablets or capsules, which appear to be ecstasy. In Hungary and the United States, this has led to accumulations of acute intoxication (26). Another new development is the detection of synthetic cannabinoids in liquids contained in e-cigarette cartridges. This is likely due to the recent growing popularity of “vaping” among young people. At low doses, the effect is quite similar to that of cannabis (more similar to that of another synth. Cannabinoids are cannabis) and mostly euphoric, relaxing and “flattening”.

In high doses, it then becomes very confusing and sedative. Now the dissolved synthetic cannabinoid is poured over the smoking mixture into the shell and everything is well stirred so that the herbs are evenly wet with the solvent and therefore the active ingredient. It is extremely important that all herbs are soaked evenly! The ready-to-soak herbal mixture is now laid out on a plate and dried at room temperature or on a heater until the herbs are no longer moist and well smoked. The development of tolerance is quite drastic and decreases relatively slowly. Each consumption slightly increases tolerance, regular consumption with too few breaks increases tolerance quite noticeably, which is why with daily consumption after a few weeks, a multiple of the initial dose should be taken. ADB-PINACA is an indazolecarboxamide that is structurally bound to Apinaca. It was first reported to the EMCDDA in November 2013 by the UK Focal Point. ADB-PINACA was associated with an outbreak of non-fatal poisonings in the United States in September 2013. Information on the extent to which synthetic cannabinoid products are consumed is limited.

However, situational awareness is improving as more and more countries include questions on the use of new drugs in their surveys of the general population. From the information currently available, it can be inferred that the prevalence of their use in the general population in Europe is low. A number of surveys have been conducted to analyse the prevalence of consumption of spice-type products, but their coverage and representativeness are still limited. A synthetic cannabinoid that belongs to the benzoylindole family. It was detected in May 2011 by German and Polish authorities. It has been found in powders and herbal smoke mixtures, sometimes in combination with other synthetic cannabinoids. It has been shown to be nephrotoxic in an animal model (dogs). A synthetic cannabinoid that belongs to the benzoylindole family. As the name suggests, it is closely related to AM-694. It was notified to the EMCDDA in July 2012 in a sample of UK plant smoking mixtures containing other derivatives of AM-694 and considered a by-product of tests to produce synthetic cannabinoids. In order to keep the side effects and risk of addiction as low as possible, you should only consume a synthetic cannabinoid every 2-4 weeks.

Each unit of consumption should consist of only a reasonable and moderate dose and should not be repeated all day, but limited to as few smoking units as possible. In order to be able to dose well, you need to make a mixture to smoke, with some cannabinoids, oral consumption is also possible, which is gentle on the lungs.